Physician profile
Som Bailey
NPI 1285168658
$56,342.24
in general payments reported to CMS, 2019-2025
15 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.46 · 2022: $716 · 2023: $554 · 2024: $54K · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $3,711 · Travel and Lodging: $1,818 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $3,711.46 |
| Travel and Lodging | $1,817.90 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,618.92 | 2022-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $22,128.68 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Sentinel |
| Edwards Lifesciences Corporation | $791.77 | 2024 | Pascal |
| Abbott Laboratories | $215.61 | 2024 | Amplatzer Amulet |
| Chiesi USA, INC. | $155.64 | 2023-2024 | Kengreal |
| Sanofi-Aventis U.S. LLC | $135.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $63.21 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.90 | 2025 | Lifevest |
| Novo Nordisk INC | $40.67 | 2025 | Wegovy |
| Terumo Medical Corporation | $38.15 | 2023 | Glidesheath Slender, Metacross Otw, Progreat |
| Amgen INC. | $32.01 | 2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $21.40 | 2025 | Wainua |
| Teleflex LLC | $19.66 | 2025 | Orsiro Mission |
| Abiomed | $18.99 | 2025 | |
| Pfizer INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Som Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.